These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 11507078)

  • 41. A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine.
    Keen JC; Yan L; Mack KM; Pettit C; Smith D; Sharma D; Davidson NE
    Breast Cancer Res Treat; 2003 Oct; 81(3):177-86. PubMed ID: 14620913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 5-azaC treatment enhances expression of transforming growth factor-beta receptors through down-regulation of Sp3.
    Ammanamanchi S; Brattain MG
    J Biol Chem; 2001 Aug; 276(35):32854-9. PubMed ID: 11443124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of Sp1 in the differential expression of transforming growth factor-beta receptor type II in human breast adenocarcinoma MCF-7 cells.
    Liu Y; Zhong X; Li W; Brattain MG; Banerji SS
    J Biol Chem; 2000 Apr; 275(16):12231-6. PubMed ID: 10766860
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transfection of the type I TGF-beta receptor restores TGF-beta responsiveness in pancreatic cancer.
    Wagner M; Kleeff J; Lopez ME; Bockman I; Massaqué J; Korc M
    Int J Cancer; 1998 Oct; 78(2):255-60. PubMed ID: 9754660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells.
    Wang J; Sun L; Myeroff L; Wang X; Gentry LE; Yang J; Liang J; Zborowska E; Markowitz S; Willson JK
    J Biol Chem; 1995 Sep; 270(37):22044-9. PubMed ID: 7665626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanisms of decreased expression of transforming growth factor-beta receptor type I at late stages of HPV16-mediated transformation.
    Hypes MK; Pirisi L; Creek KE
    Cancer Lett; 2009 Sep; 282(2):177-86. PubMed ID: 19344999
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ligand induced upregulation of the type II transforming growth factor (TGF-beta) receptor enhances TGF-beta responsiveness in COLO-357 cells.
    Kleeff J; Wildi S; Friess H; Korc M
    Pancreas; 1999 May; 18(4):364-70. PubMed ID: 10231841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells.
    Ammanamanchi S; Brattain MG
    J Biol Chem; 2004 Jul; 279(31):32620-5. PubMed ID: 15155736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Defective expression of transforming growth factor beta receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer.
    Zhang HT; Chen XF; Wang MH; Wang JC; Qi QY; Zhang RM; Xu WQ; Fei QY; Wang F; Cheng QQ; Chen F; Zhu CS; Tao SH; Luo Z
    Clin Cancer Res; 2004 Apr; 10(7):2359-67. PubMed ID: 15073112
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insensitivity to transforming growth factor-beta results from promoter methylation of cognate receptors in human prostate cancer cells (LNCaP).
    Zhang Q; Rubenstein JN; Jang TL; Pins M; Javonovic B; Yang X; Kim SJ; Park I; Lee C
    Mol Endocrinol; 2005 Sep; 19(9):2390-9. PubMed ID: 15905358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A kinase-defective transforming growth factor-beta receptor type II is a dominant-negative regulator for human breast carcinoma MCF-7 cells.
    Ko Y; Koli KM; Banerji SS; Li W; Zborowska E; Willson JK; Brattain MG; Arteaga CL
    Int J Oncol; 1998 Jan; 12(1):87-94. PubMed ID: 9454891
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic integrity of transforming growth factor beta (TGF-beta) receptors in cervical carcinoma cell lines: loss of growth sensitivity but conserved transcriptional response to TGF-beta.
    Kang SH; Won K; Chung HW; Jong HS; Song YS; Kim SJ; Bang YJ; Kim NK
    Int J Cancer; 1998 Aug; 77(4):620-5. PubMed ID: 9679767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors.
    Feng XH; Filvaroff EH; Derynck R
    J Biol Chem; 1995 Oct; 270(41):24237-45. PubMed ID: 7592630
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines.
    Nørgaard P; Spang-Thomsen M; Poulsen HS
    Br J Cancer; 1996 May; 73(9):1037-43. PubMed ID: 8624260
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epigenetic mechanisms for silencing glutathione S-transferase m2 expression by hypermethylated specificity protein 1 binding in lung cancer.
    Tang SC; Wu MF; Wong RH; Liu YF; Tang LC; Lai CH; Hsu CP; Ko JL
    Cancer; 2011 Jul; 117(14):3209-21. PubMed ID: 21246532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transfection of the type II TGF-beta receptor into colon cancer cells increases receptor expression, inhibits cell growth, and reduces the malignant phenotype.
    MacKay SL; Auffenberg T; Tannahill CL; Ksontini R; Josephs MD; Nowak M; Moldawer LL; Copeland EM
    Ann Surg; 1998 Jun; 227(6):781-9. PubMed ID: 9637541
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Involvement of RelA-associated inhibitor in regulation of trophoblast differentiation via interaction with transcriptional factor specificity protein-1.
    Minekawa R; Sakata M; Okamoto Y; Hayashi M; Isobe A; Takeda T; Yamamoto T; Koyama M; Ohmichi M; Tasaka K; Imai K; Okamoto T; Murata Y
    Endocrinology; 2007 Dec; 148(12):5803-10. PubMed ID: 17872376
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells.
    Sun L; Wu G; Willson JK; Zborowska E; Yang J; Rajkarunanayake I; Wang J; Gentry LE; Wang XF; Brattain MG
    J Biol Chem; 1994 Oct; 269(42):26449-55. PubMed ID: 7929366
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of a negative Cis-regulatory element and multiple DNA binding proteins that inhibit transcription of the transforming growth factor-beta type II receptor gene.
    Song SU; Oh IS; Lee B; Suh JK; Kim JH; Cha YD; Lee KH; Kim DH
    Gene; 2001 Jan; 262(1-2):179-87. PubMed ID: 11179682
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell lines.
    Halder SK; Cho YJ; Datta A; Anumanthan G; Ham AJ; Carbone DP; Datta PK
    Neoplasia; 2011 Oct; 13(10):912-22. PubMed ID: 22028617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.